Genmab CEO Jan van de Winkel says there are other options if the deal falls through.
发布者：BY ALBERT RONNING-ANDERSSON，转转请注明出处：https://robotalks.cn/crucial-quarter-for-genmab-jj-must-decide-on-miracle-drug/
Crucial quarter for Genmab: J&J must decide on “miracle drug”
赞 (0)
关于作者
Healthcare Costs and Dissatisfaction – Healthcare IT Today Podcast Episode 158
上一篇
20 1 月, 2025 4:00 下午
Eli Lilly gets reiterated buy recommendation before obesity pill study
下一篇
20 1 月, 2025 4:18 下午
相关推荐
-
Bitcoin ETFs could overtake gold ETFs in size within one month
The rapid growth of Bitcoin ETFs highlights shifting investor preferences, raising questions about long-term stability compared to traditional assets.The post Bitcoin ETFs could ov…
-
EOT.AI Announces the Launch of Gen AI Knowledge Builder for Industrial Enterprises
AMSTERDAM–(BUSINESS WIRE)–EOT.AI launches Twin Discuss Gen AI Data Builder to offer real-time insights with safe, non-public AI options for industrial enterprises.
-
Media Buying Briefing: How agencies navigate clients scaling back DEI, sustainability efforts
In an environment where some brands either face pressure or choose to eliminate or pull back on their diversity, social or sustainability efforts – how can media agencies continue …
-
New filter captures and recycles aluminum from manufacturing waste
Utilized in every little thing from soft drink canisters and aluminum foil cover to motherboard and rocket boosters, light weight aluminum is the second-most-produced steel worldwi…
